Kirkland & Ellis, Capital Markets (International Firms) | Chambers Greater China Region Profile

About

Provided by Kirkland & Ellis

Our capital markets team in Asia offers a full range of equity and debt capital markets products to our clients in the region, our cutting-edge advantages include over capital markets attorneys and legal professionals in the Hong Kong, Beijing and Shanghai offices working together as one team to provide a full spectrum of services to clients in the region, including HK IPOs, US IPOs, SPAC IPOs and other convertible bond, high yield and investment grade debt and follow-on offerings and PIPE transactions.

Recent work highlights include:

*Kirkland & Ellis advised Clover Biopharmaceuticals on its entry into a placing agreement.

*Kirkland & Ellis advised Vision Deal HK Acquisition Corp. on its listing of shares and warrants on the SEHK.

*Kirkland & Ellis advised Noah Holdings Limited on its global offering and secondary listing on the SEHK.

Chambers Review

Provided by Chambers

Capital Markets: Equity (International Firms) - China

Band 2

What the Team is Known For

Kirkland & Ellis has a strong track record of acting for international and local businesses and investment banks on US and Hong Kong IPOs. It additionally handles a range of secondary offerings in Hong Kong and New York and maintains strong relationships with regulators. As a Hong Kong and New York-qualified team with Chinese language capabilities, Kirkland & Ellis is well placed to advise on listings on a variety of stock exchanges. It often advises on significant deals in China's TMT and life sciences sectors.

View ranking table

Work Highlights

Provided by Kirkland & Ellis

Kirkland & Ellis advised Will Semiconductor on its USD445 million offering of 31 million global depositary receipts, each representing one A share of Will Semiconductor.

Strengths

Provided by Chambers

Kirkland provide comprehensive solutions tailored to our specific needs and solve each matter efficiently.